Inventor · disambiguated record
Allan Bradley
Also filed as: BRADLEY ALLAN
47 granted patents·58 pending applications·1,520 citations·filing 1994–2023
99Inventor score
Top patents by PatentIndex Score
105 records- 0198US9447177B2Transgenic mouse homozygous for chimeric IgH locusBRADLEY ALLAN·Filed 2012·Granted Sep 20, 2016·36 cites·6 claims
- 0298US9434782B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Sep 6, 2016·31 cites·8 claims
- 0397US10226033B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2017·Granted Mar 12, 2019·13 cites·22 claims
- 0497US10165763B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Jan 1, 2019·13 cites·16 claims
- 0597US9938357B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Apr 10, 2018·21 cites·23 claims
- 0697US9938358B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Apr 10, 2018·19 cites·23 claims
- 0797US9924705B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Mar 27, 2018·20 cites·36 claims
- 0897US9896516B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Feb 20, 2018·20 cites·11 claims
- 0997US9505827B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Nov 29, 2016·27 cites·10 claims
- 1097US9445581B2Animal models and therapeutic moleculesBRADLEY ALLAN·Filed 2012·Granted Sep 20, 2016·51 cites·27 claims
- 1196US10774155B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2018·Granted Sep 15, 2020·9 cites·26 claims
- 1296US10064398B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2014·Granted Sep 4, 2018·14 cites·25 claims
- 1396US9788534B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2013·Granted Oct 17, 2017·18 cites·19 claims
- 1496US9253965B2Animal models and therapeutic moleculesBRADLEY ALLAN·Filed 2012·Granted Feb 9, 2016·35 cites·23 claims
- 1596US6048695AChemically modified nucleic acids and methods for coupling nucleic acids to solid supportBAYLOR COLLEGE MEDICINE·Filed 1998·Granted Apr 11, 2000·325 cites·51 claims
- 1695US10730930B2Antibodies, variable domains and chains tailored for human useKYMAB LTD·Filed 2017·Granted Aug 4, 2020·9 cites·15 claims
- 1795US10149462B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Dec 11, 2018·15 cites·24 claims
- 1895US9504236B2Animal models and therapeutic moleculesKymab Limited; The Bennet Building (B930)·Filed 2015·Granted Nov 29, 2016·29 cites·15 claims
- 1994US11399522B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2021·Granted Aug 2, 2022·2 cites·13 claims
- 2094US10966412B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2018·Granted Apr 6, 2021·11 cites·21 claims
- 2194US9783593B2Antibodies, variable domains and chains tailored for human useKYMAB LTD·Filed 2013·Granted Oct 10, 2017·19 cites·18 claims
- 2293US6461818B1Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpointsBAYLOR COLLEGE MEDICINE·Filed 2000·Granted Oct 8, 2002·63 cites·4 claims
- 2393US6395487B1Method chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpointsBAYLOR COLLEGE MEDICINE·Filed 2000·Granted May 28, 2002·49 cites·19 claims
- 2492US9963716B2Chimaeric surrogate light chains (SLC) comprising human VpreBKYMAB LTD·Filed 2014·Granted May 8, 2018·12 cites·38 claims
- 2592US5614396AMethods for the genetic modification of endogenous genes in animal cells by homologous recombinationBAYLOR COLLEGE MEDICINE·Filed 1994·Granted Mar 25, 1997·319 cites·32 claims
- 2691US6136566AIndexed library of cells containing genomic modifications and methods of making and utilizing the sameLEXICON GENETICS INC·Filed 1996·Granted Oct 24, 2000·118 cites·23 claims
- 2789US2023263143A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2023·Application pending·0 cites
- 2889US2023225302A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2023·Application pending·0 cites
- 2988US2024200054A1Methods, cells & organismsKYMAB LTD·Filed 2023·Application pending·0 cites
- 3087US2023270088A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 3187US2024057572A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 3286US10337000B2Expression vector production and high-throughput cell screeningKYMAB LTD·Filed 2014·Granted Jul 2, 2019·4 cites·16 claims
- 3386US6979728B2Articles of manufacture and methods for array based analysis of biological moleculesSPECTRAL GENOMICS INC·Filed 2001·Granted Dec 27, 2005·13 cites·79 claims
- 3485US6975943B2Clone-array pooled shotgun strategy for nucleic acid sequencingSEQWRIGHT INC·Filed 2001·Granted Dec 13, 2005·33 cites·58 claims
- 3584US11606941B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2016·Granted Mar 21, 2023·1 cites·20 claims
- 3684US6207371B1Indexed library of cells containing genomic modifications and methods of making and utilizing the sameLEXICON GENETICS INC·Filed 1997·Granted Mar 27, 2001·57 cites·38 claims
- 3783US6858713B1Chemically modified biological molecules and methods for coupling biological molecules to solid supportBAYLOR COLLEGE MEDICINE·Filed 2000·Granted Feb 22, 2005·8 cites·44 claims
- 3882US11066464B2Anti-malarial antibodies that bind circumsporozoite proteinKYMAB LTD·Filed 2018·Granted Jul 20, 2021·4 cites·13 claims
- 3981US11564380B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2015·Granted Jan 31, 2023·1 cites·34 claims
- 4080US11297810B2Animal models and therapeutic moleculesKYMAB LTD·Filed 2019·Granted Apr 12, 2022·1 cites·31 claims
- 4180US2023159660A1Animal models and therapeutic moleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 4278US5602307ANon-human animal having predefined allele of a cellular adhesion geneBAYLOR COLLEGE MEDICINE·Filed 1994·Granted Feb 11, 1997·41 cites·12 claims
- 4378US2020352145A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
- 4478US2020337280A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
- 4578US2023157264A1Animal models and therapeutic moleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 4677US5569824ATransgenic mice containing a disrupted p53 geneBAYLOR COLLEGE MEDICINE·Filed 1994·Granted Oct 29, 1996·40 cites·4 claims
- 4777US2020375158A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
- 4877US2020352144A1Animal Models and Therapeutic MoleculesKYMAB LTD·Filed 2020·Application pending·0 cites
- 4977US2022287283A1Animal models and therapeutic moleculesKYMAB LTD·Filed 2022·Application pending·0 cites
- 5075US11920128B2Methods, cells and organismsKYMAB LTD·Filed 2019·Granted Mar 5, 2024·0 cites·19 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →